Literature DB >> 23115051

Enlarged hyperechogenic substantia nigra as a risk marker for Parkinson's disease.

Daniela Berg1, Stefanie Behnke, Klaus Seppi, Jana Godau, Stefanie Lerche, Philipp Mahlknecht, Inga Liepelt-Scarfone, Christoph Pausch, Niko Schneider, Alexandra Gaenslen, Kathrin Brockmann, Karin Srulijes, Heiko Huber, Isabel Wurster, Heike Stockner, Stefan Kiechl, Johann Willeit, Arno Gasperi, Klaus Fassbender, Thomas Gasser, Werner Poewe.   

Abstract

BACKGROUND: SN hyperechogenicity (SN+), determined by transcranial sonography, has been proposed as a risk factor for Parkinson's disease (PD). Recently, we reported a 17.4-fold increased risk for PD in individuals with SN+ older than 50 years within 3 years.
METHODS: This is the second follow-up of a prospective, longitudinal, three-center observational study after 5 years. Of the initial 1,847 at baseline PD-free participants 50 years or older, 1,271 underwent the 5-year reassessment.
RESULTS: Within 5 years, 21 individuals developed incident PD. Participants with SN+ at baseline had a more than 20.6 times increased risk to develop PD in this time span than those without this echo feature.
CONCLUSION: We thus confirm our finding of the 3-year follow-up examination in a longer observation time and higher number of individuals with incident PD and suggest SN+ as an important risk marker for PD.
Copyright © 2012 Movement Disorders Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23115051     DOI: 10.1002/mds.25192

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  31 in total

1.  3D transcranial ultrasound as a novel intra-operative imaging technique for DBS surgery: a feasibility study.

Authors:  Seyed-Ahmad Ahmadi; Fausto Milletari; Nassir Navab; Madeleine Schuberth; Annika Plate; Kai Bötzel
Journal:  Int J Comput Assist Radiol Surg       Date:  2015-04-11       Impact factor: 2.924

2.  Clinical characteristics related to worsening of motor function assessed by the Unified Parkinson's Disease Rating Scale in the elderly population.

Authors:  Inga Liepelt-Scarfone; Stefanie Lerche; Stefanie Behnke; Jana Godau; Alexandra Gaenslen; Christoph Pausch; Klaus Fassbender; Kathrin Brockmann; Karin Srulijes; Heiko Huber; Isabel Wurster; Daniela Berg
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

Review 3.  Developments in the role of transcranial sonography for the differential diagnosis of parkinsonism.

Authors:  Andrea Pilotto; Rezzak Yilmaz; Daniela Berg
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 4.  Biomarkers in Parkinson's disease: Advances and strategies.

Authors:  Marion Delenclos; Daryl R Jones; Pamela J McLean; Ryan J Uitti
Journal:  Parkinsonism Relat Disord       Date:  2015-09-30       Impact factor: 4.891

5.  Brainstem raphe and substantia nigra echogenicity in idiopathic REM sleep behavior disorder with comorbid depression.

Authors:  Dolores Vilas; Alex Iranzo; Claustre Pont-Sunyer; Mónica Serradell; Carles Gaig; Joan Santamaria; Eduardo Tolosa
Journal:  J Neurol       Date:  2015-05-01       Impact factor: 4.849

Review 6.  [Helpful instrumental examinations in idiopathic Parkinson's disease].

Authors:  U Walter; H Zach; I Liepelt-Scarfone; W Maetzler
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

7.  Hand function is impaired in healthy older adults at risk of Parkinson's disease.

Authors:  Gabrielle Todd; Miranda Haberfield; Patrick L Faulkner; Caroline Rae; Michael Hayes; Robert A Wilcox; Janet L Taylor; Simon C Gandevia; Jana Godau; Daniela Berg; Olivier Piguet; Kay L Double
Journal:  J Neural Transm (Vienna)       Date:  2014-05-03       Impact factor: 3.575

Review 8.  The path to biomarker-based diagnostic criteria for the spectrum of neurodegenerative diseases.

Authors:  Filippo Baldacci; Sonia Mazzucchi; Alessandra Della Vecchia; Linda Giampietri; Nicola Giannini; Maya Koronyo-Hamaoui; Roberto Ceravolo; Gabriele Siciliano; Ubaldo Bonuccelli; Fanny M Elahi; Andrea Vergallo; Simone Lista; Filippo Sean Giorgi; Harald Hampel
Journal:  Expert Rev Mol Diagn       Date:  2020-02-27       Impact factor: 5.225

Review 9.  Is there a need to redefine Parkinson's disease?

Authors:  Philipp Mahlknecht; Werner Poewe
Journal:  J Neural Transm (Vienna)       Date:  2013-05-29       Impact factor: 3.575

10.  Prediction of Parkinson's disease subsequent to severe depression: a ten-year follow-up study.

Authors:  Uwe Walter; Robert Heilmann; Lara Kaulitz; Tino Just; Bernd Joachim Krause; Reiner Benecke; Jacqueline Höppner
Journal:  J Neural Transm (Vienna)       Date:  2014-09-14       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.